| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 12,377,000 | 11,153,000 | 10,829,000 | 10,938,000 | | Cost of Revenue | 2,884,000 | 2,936,000 | 2,000,000 | 1,984,000 | | | Gross Profit | 9,493,000 | 8,217,000 | 8,829,000 | 8,954,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,784,000 | 6,847,000 | 7,508,000 | 7,806,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 450,000 | 441,000 | 426,000 | 430,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,259,000 | 929,000 | 895,000 | 718,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 6,000 | (22,000) | 13,000 | | Earnings Before Interest And Taxes | 1,272,000 | 935,000 | 873,000 | 731,000 | | Interest Expense | 89,000 | 93,000 | 181,000 | 82,000 | | Income Before Tax | 1,183,000 | 842,000 | 692,000 | 649,000 | | Income Tax Expense | 426,000 | 293,000 | 247,000 | 248,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 757,000 | 549,000 | 445,000 | 401,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 757,000 | 549,000 | 445,000 | 401,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $757,000 | $549,000 | $445,000 | $401,000 |
|
0.41% Nasdaq 
0.22 (0.35%) 
Income Statement
